RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
108 hedge funds and large institutions have $863M invested in Rubius Therapeutics, Inc in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less call options, than puts
Call options by funds: $614K | Put options by funds: $617K
44% less capital invested
Capital invested by funds: $1.55B → $863M (-$682M)
Holders
108
Holding in Top 10
3
Calls
$614K
Puts
$617K
Top Buyers
| 1 | +$9M | |
| 2 | +$6.86M | |
| 3 | +$6.12M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$2.29M |
| 5 |
Morgan Stanley
New York
|
+$1.39M |
Top Sellers
| 1 | -$4.4M | |
| 2 | -$1.81M | |
| 3 | -$1.18M | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$824K |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$730K |